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Welcome

November 2005
Dear Friends:
The term “frontier” has many definitions, among them is this entry in Webster’s New Collegiate Dictionary:
“The farthermost limits of knowledge or achievement in a particular subject.”
Whichever meaning is used, it describes a place on the leading edge of exploration and capability, populated
by pioneers, leaders and visionaries. I believe that applies directly to the goals and achievements of the
University of Tennessee Medical Center. This is why we have adopted the phrase “Expanding the Frontiers of
Medicine” and named this publication Frontiers.
In this issue, we will be exploring one of the most critical frontiers in all of medicine: cancer. As a disease,
cancer presents many challenges in patient care, education, and research. Some cancers, too, are especially
prevalent in our region and are thus of particular concern to East Tennessee patients, physicians, and
communities. The Medical Center commits a tremendous amount of our resources to the detection and
treatment of this important disease.
In fact, this entire issue is focused on some of the people and programs at the University of Tennessee
Medical Center Cancer Institute, who search the frontiers of medicine every day, seeking ways to fight the
disease that touches the lives of so many of our friends and neighbors.
I hope you find the information here both interesting and informative.
Sincerely,

Joseph R. Landsman, Jr.
President & CEO
University Health System, Inc.
Dear Alumni and Friends:
Frontiers is an excellent way to keep in touch with the Graduate School of Medicine and its role with the
University of Tennessee Medical Center. As we share our stories about medical education, research endeavors,
and of course advances in patient care, you will understand why we are a highly regarded graduate regional
medical center.
What we do each day impacts the well-being of Tennesseans, whether it be through the training of excellent
physicians—two-thirds of whom remain in Tennessee after completing residencies—or our cutting-edge
research leading to new medical opportunities.
This edition highlights the world of the medical student and shows how our cancer imaging research efforts
are being applied to patient care. We invite you to read Frontiers every quarter and welcome your comments
and suggestions for future articles.
Share Frontiers with a friend or colleague, and if they would like to be on our mailing list, we would be
honored to include them in our group of alumni and friends.
Sincerely,

James J. Neutens, Ph.D.
Interim Dean
UT Graduate School of Medicine
4
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The Toughest Trail

The Toughest Trail
One Man’s Drive to Conquer Pancreatic Cancer
4th Quarter 2005
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The Toughest Trail

Tom Cronan is interviewed by Robin Roberts on ABC’s Good Morning America

Tom Cronan is a happy man.
To him, “down” is only the
decline of a hiking trail. Yet he
faces a sobering disease that,
as he says, “respects no one.”
In March 2004, Tom Cronan, a exercise physiologist
who’s now 63, was training for a master’s decathlon and
readying himself for a second career. Then a professor at
Carson-Newman College in Jefferson City, Tennessee, he
intended to spend the next part of his life promoting
wellness programs to underserved adults. Several weeks
after telling Carson-Newman of his retirement plans, he
caught a stomach virus, and when the other symptoms
had faded, a pain remained in his stomach. “I’d never had
pain like this—a sharp pain in the middle of my gut,”
says Cronan. The following week he got a diagnosis from
the Cancer Institute at UT Medical Center:
pancreatic cancer.
Pancreatic cancer plays dirty. Initially it hides, and no
screening test as of today can detect it early. If it blocks
the bile duct, the skin may become jaundiced—a
symptom Cronan’s wife, Joan, noticed—and the urine
may darken, a sign he noted. Stool might turn chalky, a
backache might develop, or vomiting might occur after
each meal.
The location of the pancreas, buried behind the stomach,
makes it a tough target for surgery. Cronan’s tumor sat in
the head of his pancreas—the most common place,
although doctors don’t know why. “There may be
molecular differences between the tissue there and
elsewhere in the pancreas,” says John L. Bell, MD,
director of the Cancer Institute and professor of surgery.
If the cancer has grown into the portal vein (which runs
through the pancreas and drains blood from the
6
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intestines) or has spread to other organs, the treatment
options are radiation and chemotherapy. Cronan was
fortunate: his tumor had not visibly spread or invaded
the portal vein.
The surgery involved a procedure called a Whipple. Bell
and Paul S. Dudrick, MD, associate professor of surgery,
removed half of Cronan’s pancreas, his gall bladder, a
portion of his stomach, and a six-inch stretch of the
small intestine. After removing the tumor, the surgeons
connected the pancreas, bile duct, and stomach. Cronan
now takes enzymes to supplement those his pancreas
cannot supply, although enough of the organ remains to
supply him with insulin and other digestive enzymes.
He faced the difficult climb with dogged but upbeat
practicality—the same attitude he’d applied while hiking
the Appalachian Trail from Georgia to Maine. When a
fever forced him back into the hospital shortly after
surgery, he walked the halls four times a day, a quartermile at a time. “I told the nurses, ‘I can’t stay in bed,’” he
says. And when Bell suggested he join the community
advisory committee at the Cancer Institute, Cronan was
delighted: “It’s UT’s effort to get patients’ perspectives,
and that kind of activity is critical for accelerated
health care.”
A month after surgery, Cronan started six weeks of
radiation, combined with chemotherapy. “Pancreatic
cancer tends to come back locally if you approach it only
with surgery,” says Robert J. Bertoli, MD, clinical

associate professor of radiation oncology. “So we routinely
use radiation and chemotherapy. But Tom’s advantage was
having surgeons experienced with pancreatic cancer. The
Whipple surgery procedure is one of the most extensive
in oncology.”
When Cronan finished his treatments in June 2004, he
asked medical oncologist and associate professor of
medicine Stephen S. Miller, MD, if there was anything
more he could or should do. Several options for
chemotherapy remained. Cronan’s response: Bring it on.
He endured another round of chemotherapy for six more
months. In February 2005, after a CT scan of his
pancreas showed no signs of cancer, Bell cleared him to
do anything he wanted.
Cronan definitely had something in mind. During
treatments, he had begun attending weekly meetings at
the Knoxville chapter of the Wellness Community, a
worldwide nonprofit organization that provides support,
education, and hope to those with cancer. “At the
meetings you leave your cancer at the door,” Cronan says.
“You go in, and for two hours you can cuss and cry, lean
and learn. Anything goes. You see the trauma that each
person is living. You indeed can relate.”
His experience with the Wellness Community allowed a
dormant ambition to percolate: for years he had wanted
to bicycle across America. He wasted no time in planning

the trip. When his doctor suggested that his knees might
not hold up, Cronan opted for a motorcycle journey to
each of the 24 Wellness Communities in the U.S. In 42
days he rode 7,300 miles—with an appearance on ABCTV’s Good Morning America thrown in—promoting the
centers and cancer awareness. “What I hope to do is
make a difference for myself and for others,” he says. “I
want to help eliminate the guesswork of cancer.”
He also wants to help ease the hopelessness many cancer
patients feel. “No one at the Cancer Institute ever shared
the stage of my cancer with me,” he says. “It may be a
valuable part of the medical record, but unless it’s of
value to the patient, it only removes hope. The timetable
is God’s shot to call.”
It’s that optimistic attitude, says Miller, that makes
Cronan one of the most admirable patients he’s ever
seen. “And he does what we ask all our patients to do:
keep fit and active.” Cronan rides a stationary bike for
25 minutes most evenings, and plans to build back
shrunken muscle—he lost 30 pounds following
surgery—with strength training. He’s scheduled to hike
Mount Le Conte in October and is contemplating a
return to the Appalachian Trail next spring. Every month
or two he sees Miller for blood work and a periodic CT
scan. If he remains cancer-free for five years after surgery,
Miller will consider him cured. “I pretty much work
around his schedule,” the doctor says. “He’s a busy man.”
Dorothy Foltz-Gray

“What I hope to do is make
a difference for myself and
for others,” Cronan says.
“I want to help eliminate the
guesswork of cancer.”

Tom and Joan Cronan

4th Quarter 2005
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Research Update

From Research to Application:
The Clinical Use of PET/CT for Patients with Oral/Head and Neck Cancer

Early detection of malignant disease
still offers the best chance of a
favorable prognosis. Functional, or molecular,
imaging potentially offers an earlier detection of cancer
than with anatomical imaging such as Computed
Tomography (CT) or Magnetic Resonance Imaging
(MRI). Molecular imaging with Positron Emission
Tomography (PET) and a glucose biomarker 18Ffluoro-deoxyglucose (FDG) has become increasingly
widely used to diagnose and stage malignant disease.
The ability of PET to accurately stage malignant disease
depends on the tumor size, the physical specifications of
the PET scanner, and the avidity of the cancer cells to
take up FDG. Recently, fusion devices that image both
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anatomy (CT) and function (PET) have been
developed, offering the best of both worlds: functional
abnormalities can be accurately localized and the
functional status of anatomical abnormalities can be
immediately assessed.
Combined PET/CT scanners have been commercially
available only for the past four years. During this
period, multi-slice CT detectors have been introduced
and PET/CT scanners now incorporate up to 64-slice
CT. The PET components comprise fast LSO detectors
with an intrinsic spatial resolution around 4 mm. The
first 16-slice spiral CT scanner in combination with the
new fast, high-resolution PET detectors, developed by

CPS Innovations, Knoxville (now Siemens Medical
Solutions Molecular Imaging) was installed at UT
Medical Center in October 2003. Since that date, over
2000 cancer patients have been successfully scanned on
the PET/CT at the Medical Center.
One region of the body where full advantage can be
taken of the high spatial resolution of the new PET/CT
scanner is in the head and neck. The ability to resolve
small structures, both normal and abnormal, is essential
for accurate staging of oral/head and neck cancer.

PET/CT to Stage Oral/Head
and Neck Cancer
The American Cancer Society estimates that
approximately 29,370 patients will be diagnosed with
cancer of the oral cavity and oropharynx during 2005.
Treatment failures of oral/head and neck cancer seem to
be related to the development of recurrent disease in the
head and neck region, new primary cancers in this area,
and distant metastatic disease. To this end, the ability to
more effectively identify subclinical disease in a timely
fashion should enhance the survival rates of these
patients. In essence, early detection could be lifesaving.
The evaluation of patients with oral/head and neck
cancer frequently involves first obtaining conventional
CT scans. These studies allow for better preoperative
visualization of lymph nodes in the neck and other
structures planned for removal during surgery. In so

doing, CT scans provide an anatomic evaluation of
structures in a given region, rather than a physiologic
evaluation. CT scans are not able to ascertain the exact
character of mildly enlarged lymph nodes in the neck in
oral/head and neck cancer patients, as often occurs after a
biopsy of the primary cancer. With this problem in mind,
our experience with PET/CT has proved to be beneficial
in the management of these patients. In the oral/head
and neck oncology patient, PET/CT has frequently been
shown to be more accurate than conventional CT in
depicting unexpected foci of neck metastases that were
not seen or difficult to observe on conventional CT
scans, or whose character was uncertain. In addition,
abnormal incidental foci of hypermetabolism may be
identified that may or may not be related to the neoplasm
for which the patient is being scanned. In practical terms,
we have identified three specific advantages of obtaining
PET/CT in the initial evaluation of patients with
oral/head and neck cancer:
1. Assessment of subclinical disease in the lymph
nodes in the neck that might alter the neck surgery
treatment plan
2. Early assessment of synchronous second
primary cancers
3. Assessment of distant metastatic disease that might
require refinement of treatment recommendations
These advantages will be illustrated with three specific
oral/head and neck cases where PET/CT scanning played
an important role.
Eric R. Carlson, DMD, MD, FACS and David W. Townsend, PhD

Dr. Townsend (left) and
Dr. Carlson review the
PET/CT images of a patient
with cancer of the neck.
4th Quarter 2005
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Case Study 1
A 69-year old gentleman was referred for treatment of a biopsy proven
cancer of the left lower jaw (figure 1). A complete history and physical
examination identified stage IV squamous cell carcinoma of this area, without
clinical evidence of spread of the cancer to the lymph nodes in the neck. The
patient underwent a staging PET/CT scan that identified hypermetabolic
activity in the known site of cancer in the left mandible (figure 2a-c), as well
as a mass associated with the left kidney (figure 3). Surgery consisted of
removal of the left mandible and upper lymph nodes in the neck, as well as
exploration and partial removal of the left kidney. The kidney demonstrated
renal cell carcinoma. The PET/CT study permitted early diagnosis of the
second cancer in the kidney. This diagnosis would not have been made had
the patient undergone conventional CT imaging only of the head and neck
region in preparation for the removal of the cancer in this area.

Figure 2a

Figure 2b

Figure 2c

Figure 2a-c: PET/CT fused images identify the known cancer in the left lower jaw.

Figure 1: A radiograph of the jaws of
this patient showing destruction of bone
in the lower jaw.

Figure 3: Additional images
showed a hypermetabolic focus
associated with the left kidney,
suggestive of a second cancer in
this area.

Case Study 2
An 82-year old woman was referred for evaluation and management of a
cancer of the right tongue. A complete history and physical examination
revealed a 3 cm cancer of the tongue without clinical evidence of neck
disease. The patient underwent a staging PET/CT that identified
hypermetabolic activity within the tongue (figure 4a) the lymph nodes of the
neck (figure 4b) as well as a focus of hypermetabolic activity within the right
thyroid gland (figure 4c). The patient underwent surgery consisting of removal
of the right tongue, the lymph nodes of the right neck and exploration and
removal of the right half of the thyroid gland. The pathologic examination of
the specimens disclosed the expected cancer in the right tongue, as well as
two lymph nodes containing cancer in the neck dissection specimen. The
pathologic examination of the thyroid gland revealed a second primary
cancer. The value of the PET/CT study in this case is that the cancer of the
right thyroid gland would otherwise have not been diagnosed in a timely
fashion had only isolated conventional CT scans been performed.

Figure 4a

Figure 4b

Figure 4c
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Figure 4: PET/CT fused images identify the known cancer in the right tongue (figure 4a),
as well as a hypermetabolic lymph node in the right neck (figure 4b) that was not able to
be palpated on clinical examination of the neck. Additional images disclosed a
hypermetabolic focus within the right thyroid gland (figure 4c), highly suggestive of a
second cancer in this area.

Case Study 3

Figure 5: PET/CT fused
images showed several
hypermetabolic lymph
nodes in the left neck.

Figure 6a: Additional PET/CT
images identified hypermetabolic
foci in the right hip.

Figure 6b: The additional
PET/CT images also
identified hypermetabolic
foci in the thoracic spine.

An 80-year woman was referred for evaluation and
management of a biopsy proven cancer of the left
jaw and surrounding soft tissues. Her main complaint
at the time of evaluation was severe pain. Complete
clinical evaluation was significant for stage IV
squamous cell carcinoma of this area without spread
of the cancer to the lymph nodes in the neck. The
patient underwent a staging PET/CT that identified
increased metabolic activity in the left jaw as well as
a large number of hypermetabolic lymph nodes in the
left neck (figure 5). Moreover, multiple foci of distant
hypermetabolic activity were noted in the bilateral
lungs, thoracic spine, and ilium (figure 6a-c). The
distant metastatic disease would not have been
identified had an isolated CT scan of the neck been
routinely performed. As such, the PET/CT scan
provided essential information to share with the
patient and to plan appropriate treatment for a
patient previously not known to have a very poor
prognosis.

Figure 6c: A whole body PET image shows these
disseminated metastatic foci in one image.

7 The Seven Warning Signs of Cancer
If you or a loved one notice any of the following seven warning signs of cancer, report them to your
doctor immediately!

1
2
3
4
5
6
7

Change in bowel or bladder habits
A sore that does not heal
Unusual bleeding or discharge
Thickening or lump in breast or other part of body
Indigestion or difficulty in swallowing
Obvious change in wart or mole
Nagging cough or hoarseness
Every type of cancer has its own unique characteristics - such as its location, type, growth and how quickly it
spreads to other tissues and organs. That's why an early diagnosis of cancer allows your doctor time to treat the
cancer for your individual case and to develop the best treatment plan for you. It is important to know and
recognize the early symptoms and signs of cancer.
4th Quarter 2005
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Cancer Imaging and
Tracer Development Research Program
The Cancer Imaging and Tracer
Development Research Program
(CITDRP) was established at the University of
Tennessee Medical Center in Knoxville, Tennessee in
February 2003 under the direction of David
Townsend, PhD. Complementing Positron Emission
Tomography (PET) initiatives at UT Medical Center
since the early nineties and benefiting from the
support of nearby CTI Molecular Imaging, the
recognized world leader in PET technology and
innovation based in Knoxville, the mission of the
CITDRP is to create a world-class center for
translational research using molecular imaging. The
establishment of the CITDRP at the University of
Tennessee was the inspiration of Ron Nutt, PhD,
formerly President and CEO of CTI Molecular
Imaging in Knoxville. This program involves the
development of new molecular biomarkers, evaluation
of such biomarkers in appropriate animal models, and
their subsequent introduction into the clinical arena
for patient imaging. The CITDRP is based within the
UT Graduate School of Medicine with faculty
members holding appointments in the Departments of
Medicine and Radiology.
The program is organized into three principal
components: Physics and Methodology,
Radiopharmaceutical Development, and Applications
for both animals and humans. The Physics and
Methodology component is directed by Dr. Townsend
in association with Bjoern Jakoby, MS who is
responsible for a number of PET instrumentation and
methodology projects.
Meixiang Yu, PhD was recently recruited from
Harvard University to lead the radiotracer and
biomarker development program with the
participation of organic chemist Fang Gao, PhD. This
recently-established PET radiochemistry program
shares the operation of a cyclotron with PETNET
radiopharmaceutical production and a research hot cell
with Department of Radiology faculty.
Meixiang Yu, PhD, at work in the lab.
12

Frontiers

The CITDRP’s focus is the imaging of cancer,
with a current workload of five to seven
Figure 1: A 31 year-old male withclinical
lymphoma staged
on the Sensation
PET/CT
scans and one to two
16 PET/CT scanner in the UT Cancer Institute prior to commencing
research
studies
per day.
chemotherapy. The PET/CT scan reveals
the extent
of malignant
disease.
Claude Nahmias, PhD
recently joined the
program to head both the
animal and human
research applications
component with the close
participation of Karl
Hubner, MD. The new,
$600,000 animal imaging
facility will be managed by Xukui Wang, MD, also
recruited recently from Harvard. The facility has four
scanning suites with PET and SPECT/CT imaging
capability, animal holding rooms and laboratory
workspace. Veterinary technologist James Avenell, BVSc
LVMT directs the operation of these imaging devices.
The animal imaging program involves close
collaboration with the UT College of Veterinary
Medicine and with the amyloid imaging program of
Alan Solomon, MD and Jon Wall, PhD, who will also
be responsible for operation of the animal imaging
equipment, in particular the SPECT/CT. Establishing a
strong animal imaging initiative for translational
research is an essential part of the CITDRP mission.
Collaboration with radiologist Greg Daniel, DVM and
oncologist Amy LeBlanc, DVM from the UT College
of Veterinary Medicine plays an instrumental role in
meeting this goal by bridging the gap in translational
research between micro imaging of small animal models
and the imaging of clinical patients and can only be
undertaken in an academic environment that includes a
high-level veterinary college such as the one at UT.

Paschal, BS. The primary focus of the CITDRP is the
imaging of cancer (Figure 1), with a current workload
of 5-7 clinical PET/CT scans per day and 1-2 research
studies. However, the importance of PET imaging in
other areas of clinical research is demonstrated by ongoing projects in both cardiology with the collaboration
of Woody Besozzi, MD, and in neuroscience with John
Dougherty, MD, Kent Hutson, MD and Yongxia Zhou,
PhD. Current research projects in cancer imaging
include monitoring response to chemotherapy with
medical oncologist Wahid Hanna, MD, and staging
head and neck cancer prior to surgery in collaboration
with surgeon Eric Carlson, DMD, MD, FACS (see
article in this issue). Radiation oncologist Khanh
Nguyen, MD has recently joined the University of
Tennessee in Knoxville to focus on both his clinical
practice and on research with image-guided radiation
therapy planning. In early 2006, the CITDRP will
acquire a second, state-of-the-art PET/CT scanner as
part of an NIH-funded collaborative initiative with
Siemens Molecular Imaging. The new scanner will be
an advanced design offering improved sensitivity for
PET imaging.
After more than two years at UT, the Cancer Imaging
and Tracer Development Program is now wellestablished and is expanding to contribute to other areas
of research in which PET and PET/CT can play a
significant role, and also offer potential for peerreviewed NIH funding.
David Townsend, PhD

In addition to these animal imaging facilities, a state-ofthe-art high resolution 16-slice PET/CT scanner has
been installed in the Cancer Institute at the Medical
Center. The scanner is used for both routine clinical
and clinical research studies. Operational aspects of the
PET/CT research program are the responsibility of
technologist Misty Long, RT(N)(R) and Chris Carr,
RT(R), CNMT as the lead technologist responsible for
operation of the scanner for clinical PET/CT studies.
All administrative aspects are managed by Linda
Xukui Wang, MD, explains how the animal imaging PET operates.
4th Quarter 2005
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Preston Medical Library

Preston Medical Library
Consumer Health Information Service

Answers with a
Personal Touch
You’ve just learned that you have
diabetes. What now?
Your physician recommends a medical
procedure. How is it done and what
information will it provide?
You’re not comfortable looking up
medical information on the Internet.
Where can you turn?
If you find yourself faced with similar questions, the
Preston Medical Library at the University of Tennessee
Graduate School of Medicine may have the answers
you need.
At the Preston Medical Library and Learning Resource
Center, both patients and community members can
make use of the Consumer and Patient Health
Information Service, a free information resource as close
as your telephone or computer. If you have health-related
questions, call the service at 865-544-9525 or e-mail
your questions to library@mc.utmck.edu. A medical
librarian will search for answers on any health topic, and
the new knowledge will help you feel more confident as
you and your doctor talk and make decisions about your
health.
“That’s a true benefit of the service,” says Sandy
Oelschlegel, the library’s director. “Consumers can gather
information about health concerns and have more
productive relationships with their physicians.” But the
information is just that, she adds—information, not
medical advice.
14
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Contact Preston Medical Library
Consumer and Patient Health
Information Service
The Preston Medical Library Consumer and Patient
Health Information Service at the UT Graduate School of
Medicine is funded in part by charitable gifts from grateful
patients and members of the community. One couple with
good reason to feel gratitude is the Fordhams. For 20 years,
the library has provided Joellen and J. Lynn Fordham with
critical health information.

Hours of Operation:
Monday - Friday, 9:00 am - 5:00 pm
Phone: 865-544-9525
E-mail: library@mc.utmck.edu
Website: www.tennessee.edu/healthinfo

“I owe my life to the library staff,” says J. Lynn Fordham.
“During four medical crises, I received information and
help from the library. In each case, the input provided a
sound basis for my decision on treatment that was
lifesaving. The library staff did more than supply helpful
medical literature. They taught my good wife how to find
and survey health information.”
The Fordhams have shown their appreciation for the
library and its staff in many ways, including a charitable
gift to fund the transformation of the library conference
room into an integrated multimedia learning center.
“We are indebted to the library, the hospital, and the
Graduate School of Medicine,” Mr. Fordham says. “They
understand human suffering. And they’re ready to help
before the need arises.”

J. Lynn and Joellen Fordham

Amanda Johnson

4th Quarter 2005
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Weekly Input From
Multiple Disciplines
Improves Cancer Care.

In 1978, a group of doctors in the radiation and
medical oncology divisions at the University of
Tennessee Medical Center began meeting every
Wednesday to discuss cases. “Four or five of us met
in a little hole and reviewed xrays with radiologists,
and that was it,” says Wahid T. Hanna, MD,
professor of medicine and chief of the
Hematology/Oncology Division. “Then we
expanded to involve pathologists. We began to say to
other doctors, ‘By the way, we’re presenting your
case. Would you like to be there?’”
Twenty-seven years later, the Medical Center’s
Cancer Institute holds a number of multidisciplinary
meetings, formally called multidisciplinary tumor
conferences, every week. It was the first medical
facility in the region to hold these dedicated
conferences. The meetings include a general
conference on Wednesdays at which attendees
discuss any type of malignancy, a lung and
esophageal conference on Thursdays, a breast
conference on Fridays, and a head and neck
conference held twice monthly.
“The main purpose of the conferences is to bring
together a group of doctors who focus their efforts
on treating cancer patients,” says John L. Bell, MD,
director of the Cancer Institute and professor of
surgery. “You can’t always open a textbook and
implement a cancer plan. It benefits the patient to
have specialists look at the case and develop an
individualized tailored plan: the surgeons, the
radiologists, the pathologists, the radiation
oncologists and medical oncologists. The patient gets
optimum care through the collective wisdom of a
multidisciplinary team involving numerous
physicians and healthcare professionals.”
4th Quarter 2005
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UT Medical
Center Tumor
Conferences
Breast
Friday
Pulmonary
Thursday
General
Wednesday
Head & Neck
Every other
Monday

The meetings, often attended by more than 40 people, may also include a patient’s primary
doctor, as well as geneticists, social workers, nutritionists, nurses, chaplains, clinical-trials
staff, residents, and medical students. Bell notes, “There’s a whole spectrum of people at
these meetings that represent the medical and patient communities.” Multiple scientific
studies, he says, indicate that the multidisciplinary approach improves patient outcomes.
For example, according to a nine-year melanoma survival study completed in 2002 at the
Cancer Institute, five-year survival rates at UT Medical Center were 10 percent higher than
the national average.

“The patient gets optimum care

When a physician wishes to
through collective wisdom of a
present a case, he or she works
multidisciplinary team involving
with a conference coordinator
numerous physicians and health
who ensures that all necessary
materials—slides, scans, X-rays—
care professionals.”
are available at the meeting. After
the doctor lays out the case, everyone participates in the discussion. “Sometimes there is a
controversy about the management, and different views, even arguments,” says Hanna. “But
eventually we end up with a plan that’s usually the right one—because, after all, a patient is
in our hands and we want to do what’s best for them.”
The meetings also offer an opportunity to learn about new research findings and treatment
options. “It’s very refreshing to discuss cases and exchange ideas,” Hanna says. “And you
keep up-to-date, because you discuss the latest published information. Each week is like an
update for all of us of where we stand in state-of-the-art cancer care.”

Dr. Susan Huntsinger, medical oncologist,
consults with cancer survivor Peggy Iachetta.
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Robert J. Bertoli, MD, clinical associate
professor of radiation oncology, has particular
praise for the breast conferences. Every kind of
case is presented, from the routine to the most
complex. Bertoli says: “Those conferences are
the best I’ve ever been to. They’re a
combination of a very academic and workoriented conference. And the surgeons have
been the driving force for that.”
The economy of the multidisciplinary
approach is impressive too, says Bertoli, who
trained at Hahnemann Hospital in
Philadelphia, Pennsylvania and has been at the
Medical Center since 1994. At Hahnemann,
he had to trek from doctor to doctor to confer
about cases of breast cancer, because the
hospital didn’t have breast conferences at the time.
“You got the work done,” he says, “but it wasn’t as
efficient. If you have everyone involved in one room,
then you learn what people need to know, what’s
important to each specialty. And that really streamlines
care.” In fact, data show that the majority of patients
at the Cancer Institute receive a care plan within five
working days. And most of the time, they know that
many specialists have reviewed their case.
For Bertoli, the conferences also enhance
communication between specialties. “Sometimes just
the inflections in someone’s voice are important,” he
says. “A radiologist may look at an X-ray and say, ‘The
calcifications are probably benign, but we ought to
follow up.’ To have them say that in the conference
gives you a sense that you really need to take a look, so
you do an extra-careful follow-up. That’s different
from just reading a report.”
Hanna agrees. “Let’s say there’s a patient with a liver
lesion. It’s nice to hear from the surgeon if it can be
removed surgically. If it can’t, can the interventional
radiologist do a radio-frequency ablation [a procedure
that kills tissue with heat generated by electrical
energy]? Or can it be treated with chemoembolization
[a procedure in which chemotherapy drugs are fed
through a catheter directly into the tumor’s blood
supply]? All these things are discussed as options, and
every specialty speaks, and so in the end we come up
with the best approach for the patient—hopefully
giving the patient the best chance for cure, which is
what we strive for.”
Dorothy Foltz-Gray

A Message from

Dr. John L. Bell
Cancer care in the United
States continues to
improve as evidenced by
the ever increasing
number of survivors.
Advances in cancer
diagnostic technologies,
treatment modalities and
new methodologies for
prevention and early
detection of cancer have
been realized through years of research. Basic
laboratory research at the cellular and subcellular
level continues the search for keys to unlock the
“cancer questions.” These basic research findings
are constantly translated to the bedside resulting in
improved cancer care. Much progress has been
made, but much additional work lies ahead to win
the battle against cancer.
This is where you come in! Funding is needed to
continue our search for answers. Few industries run
on margins as narrow as healthcare. Translated into
reality, this means fewer discretionary dollars are left
in health care to fund critical research projects. It is
only through philanthropy that such dollars will be
available to expand current research efforts.
The Cancer Institute has several established gift
funds to support education, research, and clinical
care initiatives (see page 29). Additional gifts are
needed to continue our research efforts toward
finding a cure. Donors may give to one of our
existing funds or may consider establishing special
purpose funds in honor of or memory of loved ones
or friends. For more information about how you can
make a difference, please contact the UT Medical
Center Development Office at 865-544-6611.
Your serious consideration of our needs is greatly
appreciated.

4th Quarter 2005
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Medical School
After earning their undergraduate
degrees, students accepted to the University of
Tennessee Health Science Center College of Medicine
do their first two years of study in Memphis. The
medical students complete necessary coursework and
participate in the Longitudinal Community Program,
which provides early longitudinal exposure to the realworld aspects of medicine. During these initial two
years, the program emphasizes continuity of care,
interpersonal skills, and physician roles and
relationships, as well as clinical decision-making.
The third and fourth years of medical school are
dedicated mostly to clinical rotations, called clerkships
in the third year. While some rotations are offered only
in Memphis, most can also be completed in Knoxville
or Chattanooga, a factor that makes the program truly
statewide. All clinical rotations are conducted under the
watchful eyes of attending physicians, or faculty
physicians who supervise the students’ work.
Medical students are required to take three board
examinations. Successful completion of all four years of
medical school and satisfactory scores on the board
exams earn students the doctor of medicine degree. The
20

Frontiers

The First Big Step to
Becoming a Doctor

newly minted physicians must then complete residency
programs in their selected specialties—for instance,
internal medicine, family medicine, surgery,
anesthesiology, or obstetrics/gynecology. These
residencies are collectively known as graduate medical
education, and every year, doctors choose the UTGSM
in Knoxville for their residency training.
The UT Graduate School of Medicine’s program
emphasizes a team approach to patient care. Close
collegial relationships among attending physicians,
residents, and medical students allow licensed residents
to work with the faculty physicians, nurses, and other
medical professionals in determining treatment
strategies. The team reviews each patient’s case and
decides on the most effective plan of care.
“Patients at UT Medical Center get the best of both
worlds,” says Eli Jones, a fourth-year medical student.
“The medical team approach combines the knowledge
of the faculty and attending physician with that of the
residents and students. The patient benefits from the
wisdom of the attending physician and the detailoriented considerations of the residents and students.”

In the next issue, Focus on Residency.

Athlete to Physician

The Story of Eli Jones

Raised on a farm in Columbia, Tennessee, Eli Jones learned
hard lessons at an early age. By the time he turned 10, he
knew the rigors of keeping a working farm productive. He
had also discovered how it felt to lose his mother, a vibrant,
athletic school teacher who died four months after learning
that her flulike symptoms were signs of aggressive leukemia.
Jones, a versatile athlete, was a member of the basketball,
football, baseball, and track teams, and he was
valedictorian of his 1997 Salem High School class. He
received numerous scholarship offers from universities and
colleges all over the country. But tradition ruled his heart.
His parents had graduated from UT, and he was
determined to follow in their footsteps. After a satisfying

look at the biochemistry department and
encouragement from football coach Phillip Fulmer, he
became a full-fledged Volunteer.
“I was a red-shirt freshman that first year, which meant
I didn’t dress out for the games—but I practiced every
practice,” says Jones, smacking his fist into his hand. “I
was on the squad that played against the first string.
Boy, did I take some hits!”
By the end of the 2001 season, he’d earned a letter,
received his second Academic All-SEC honor, and
graduated magna cum laude in cellular and molecular
biology. Then he embarked on what he calls “the
hardest job of my life.” He entered medical school at
the University of Tennessee, Memphis.
“The studying was relentless,” he says. “I went to class
from eight in the morning to four in the afternoon,
then studied until eleven at night. Finally reality set in.
I had always been at the top of my class. At med school,
I was struggling just to be in the middle. A lot of
brilliant people go to medical school. They’re the best of
the best.”
Jones, now a fourth-year medical student, did his thirdyear clerkships in pediatrics, neurology, and psychiatry
in Memphis. After that he moved to Knoxville to tackle
rotations in internal medicine, obstetrics and
gynecology, surgery, and family practice at the UT
Graduate School of Medicine. He’s also completing
electives and weighing the question of which medical
specialty to choose. “I’m very interested in
anesthesiology,” he says. “I’ve always wanted to use my
hands to help people, and I’ve always tried to show
people compassion. As an anesthesiologist, I can
do both.”

“I have always wanted to use my hands to
help people, and I have always tried to
show people compassion. As an
anesthesiologist, I can do both.”

Jones leans forward, extending his open palms. “To be
able to use my knowledge and hands to heal others is
the ultimate job on the planet.”
Lea Anne Law

Eli Jones
4th Quarter 2005
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In Search
of Cures

Clinical Trials Push
Toward New Treatments
Approximately 400 medicines for cancers
are in development worldwide—and the Cancer Institute
at the University of Tennessee Medical Center is helping
to push that process forward. At any one time, the
Institute is involved in 35 to 45 clinical trials—research
studies that determine the safety and effectiveness of new
therapies. Most trials are funded through the National
Cancer Institute (NCI) or sponsored by pharmaceutical
companies.
A clinical trial begins with a NCI-approved protocol, or
trial plan created by a sponsor and offered to clinical
research institutions like the Cancer Institute at UT
Medical Center. A five-person clinical trials staff keeps
doctors informed about trial options. The Cancer
Institute’s Scientific Peer Review Committee evaluates
each study and decides whether or not to participate in it.
Then the protocol is submitted to the UT Graduate
School of Medicine Institutional Review Board for
approval of the study. The Review Board oversees every
trial and oversees participant safety. The dedicated
22
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oncology trials staff coordinates trial conduct, including
the screening and enrollment of research participants as
well as follow-up and data collection.
The trials range in focus from prevention to treatment,
from patients with advanced cancer to those who are at
high risk or who have just been diagnosed. “Not only do
clinical trials provide Cancer Institute patients with the
newest treatments, they also allow physicians to
contribute to improvements in medicine,” says Renee
Hawk, MPH, administrative director of the
Cancer Institute.
Some trials are particularly innovative, like one
investigating a personalized vaccine for kidney cancer.
Following surgery, a tumor tissue sample from the
patient is sent to a specialty lab, where scientists create a
unique vaccine within weeks. A therapy for colon cancer
involves Avastin (generic name: beviacizumab), one of a
new class of drugs called monoclonal antibodies that
attack the blood vessels surrounding a tumor, cutting off

its blood supply. A third trial for non-small-cell lung
cancer uses Tarceva (erlotinib), a drug that targets a
protein necessary to cancer cell growth.
“These trials lead to scientific advances that increase
our understanding of cancer,” says Barbara Munsey,
clinical trials manager at UT Medical Center. “And
every doctor at the Cancer Institute is involved. It’s
part of our mission.”
For more information on our clinical trials, please
call 865-544-9773.
Dorothy Foltz-Gray

Three Phases of Clinical Trials
Dose
Escalation
Trials

I

The first step in testing a
new treatment in
humans. What’s the
best dose?

Efficacy
Trials

II

The focus is learning if
the new treatment is
effective. Does this
treatment cause a
response?

Randomized
Trials

III

These compare the new
treatment with the
standard treatment.
Which treatment is
better?

Patient Testimony
Sharon Lackey was busy taking care of her
husband, Gene, who was receiving treatments for
end-stage renal cancer, when she received the
news that she had two types of breast cancer—
one a slow growing type and the other, a very
aggressive, fast-spreading form that returns in 80
percent of patients. Instead of taking a stance of
self-pity, Sharon and her husband teamed up for
the fight of their lives. That was November 2003;
today they are still a dynamic team.
Sharon had surgery to remove the tumors in her
breast and lymph nodes, then chose to see Dr.
Wahid Hanna, her husband’s medical oncologist.
Dr. Hanna discussed options with her…she could
receive one of the standard therapies or enroll in
a clinical trial that may prevent the return of her
aggressive cancer by building antibodies and
blocking tumor cell growth. After reviewing the
information on the clinical trial and searching the
Internet, Sharon felt she could make an informed
decision about her care. Sharon remembered
someone telling her, “Better to lose hair now and
have gray hair later.” She couldn’t agree more,
and decided the clinical trial was right for her.

More than a year after enrolling in the clinical
trial and enjoying life as a cancer survivor,
Sharon now volunteers in the chemotherapy room
encouraging others in their fight against cancer.
When asked if she would recommend a clinical
trial to others, Sharon says, “Most definitely, but
it is up to each person to look at their own
situation. Prayer has a lot to do with it. There
were lots of people praying for us and I think that
tipped the scales.”
Heather Grieve
4th Quarter 2005
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the

Wheels
of
Women’s
Health

Statewide Grant
Yields New Mobile
Mammography
Unit—and More

When Kathy Cook, 49, climbed into
the University of Tennessee Medical
Center’s new mobile mammography
unit last summer, she hadn’t had a
mammogram in four years, despite her
family history of breast cancer. The
reason: An off-site medical appointment
would take too much time from her work at
the Melaleuca Company factory in Knoxville.
But with the mobile unit parked outside the
factory’s door, Cook could be back on the job in 15
minutes.
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She’s one of many women who are benefiting from the
It didn’t take long for East Tennessee representatives to
$1,122,834 Tennessee Women’s Health Initiative
agree on the need for a new mobile unit. UT Medical
(TWHI) grant awarded by Tennessee Attorney General
Center has had a mobile mammography program since
Paul Summers in January 2004. The three-year grant
1988, but for several years, the old unit had experienced
provided $292,500 toward the purchase of the
increased maintenance problems that sometimes
mammography unit that cost almost $500,000.
disrupted the program. The new unit hit
The grant initiative began in July 2003,
the road in June of this year, bringing
when the National Consortium of Breast
on-site mammograms to numerous
Centers, Inc. in Warsaw, Indiana
women in its first two months.
The new unit hit the
informed Linda B. Cruze, RN, BSN,
The program screens many
road in June of this
CMC, coordinator of the Breast
women throughout East
Care Service at UT Medical Center,
Tennessee annually and visits
year, bringing
that the attorney general had
local businesses, churches,
mammograms to
funding to offer. Would the center
health departments, and senior
help develop a statewide grant aimed
centers,
sometimes multiple
numerous women in its
at improving women’s breast health?
times per year. The unit staffed
first two months.
by a driver/receptionist and
Cruze began combing the state for
radiology technologist logs
medical professionals who could represent
thousands of miles, providing services
each of four regions—East and Northeast
10 to 12 hours a day four to five days
Tennessee, Mid-Tennessee East, Mid-Tennessee West,
each week.
and West Tennessee. She also contacted county health
department representatives that offer the Tennessee
The Cancer Institute also operates the Breast Health
Breast and Cervical Early Detection Program, funded by
Outreach Program (BHOP), designed to enhance the
the Centers for Disease Control and Prevention in
breast health education of underserved women in East
Atlanta. Six to eight core group members met in
Tennessee. Paige Huggler, the program coordinator of
Nashville every six weeks or so, sorting out breast-care
BHOP, works with businesses and other organizations
needs in each region.
in the region to provide on-site education sessions

UT Medical Center’s new
mobile mammography van hit
the road in June 2005.
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“Our goal was to set a
standard for clinical
breast exams and to
measure competency,”
says Cruze.

where women have the option of signing up for
mammograms once they have completed the education
portion of the program.
“Sometimes a company will be hesitant about the
outreach program,” says Huggler. “But once they see
how seamless the process is, they’re very open to it.”
In addition to the mobile-unit funding, UT Medical
Center received a $70,000 grant to be used for the
development of an eight-hour clinical breast
examination and instructor certification pilot program
for healthcare providers, “the first-ever comprehensive
clinical breast exam certification course,” Cruze says.
The pilot program, completed in October of this year,
was offered free to physicians, nurses, and nurse
practitioners in each of the four state regions. “Our
goal was to set a standard for clinical breast exams and
to measure competency,” says Cruze. The National
Consortium of Breast Centers will launch a nationwide
version of the program at its March 2006 meeting in
Las Vegas.
Another portion of the Tennessee Women’s Health
Initiative grant, $13,500, went to raise awareness of
screening and diagnostic services among AfricanAmerican and Hispanic residents of the state. So far
Cordell Simpson, the faith-based program’s
coordinator, has reached more than 4,000 parishioners
and 300 African-American clergy members in East and
Northeast Tennessee and in Chattanooga.
Dorothy Foltz-Gray
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Paige Huggler talks
with patients about
breast care

The Gift in Giving

GiftinGiving

the

Planning Can Benefit Both Donor and Charity

Over the years the University of Tennessee Medical
Center has benefited from many charitable gifts made by
grateful patients and their families, by physicians who
trained or practice at the Medical Center or refer patients
there, and by employees and other friends. The Tom and
Katherine Black Neonatal Intensive Care Unit, the Heart
Lung Vascular Institute, the Pastoral Care program, the
Cancer Institute, the Preston Medical Library, and the
UT Graduate School of Medicine are just a few of the
numerous facilities and programs that excel as a result of
generous private gifts.
As the calendar year closes, many individuals consider
how best to give to charitable entities like UT Medical
Center. Here are some suggestions to help you with the
process. Because certain charitable gifts are not subject to
federal income tax, itemizing deductions on your tax
return may allow you to donate more than you thought
possible. The type of gift you choose is important. Cash,

for example, may reduce your income tax by as much as
50%; a gift of stock, bonds, or other appreciated assets
may lower your capital-gains tax. Or by giving a life
insurance policy, retirement account, bequest, or other
financial instrument related to your estate, you may be
able to increase the size of your gift.
Timing is also crucial. Reviewing your individual
circumstances with a financial adviser, attorney, or
accountant as the calendar year closes may help you feel
more comfortable about making a gift. The University of
Tennessee Medical Center Office of Development would
welcome the opportunity to discuss specific gift options
with you or your advisers.
For your convenience, we’ve provided an envelope you
can use if you’re ready to make a gift. If you would like to
discuss other gift opportunities, please contact the UT
Medical Center Development Office.
John J. Sheridan

Property
Donated
Cash
Appreciated
Property
Retirement Assets
Life Insurance
Gift by Will

Income Tax
Savings

D
D
D
D
D

Capital Gains
Tax Savings

Estate Tax
Savings

University of Tennessee
Medical Center
Office of Development

D
D
D
D

1520 Cherokee Trail
Suite 110
Knoxville, TN 37920
865-544-6611

Remember time spent deciding what, when, and how to best make your gifts
can result in maximum tax savings and financial benefits.
4th Quarter 2005
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New Tax Law New Opportunities
Events in 2005 have generated an unprecedented response
and Americans have responded with record levels of
charitable giving to assist those in need.
Congress has also acted to encourage additional charitable
giving by changing tax laws to help Americans fund relief
efforts while continuing support for their traditional
charitable interests.
The Katrina Emergency Tax Relief Act of 2005 includes a
number of important charitable giving provisions. The
Act provides special tax treatment for individuals who
volunteer their time or otherwise provide assistance to
affected individuals and includes special incentives for
those who make charitable gifts of cash before the end
of 2005.

Expanded tax incentives
Our nation’s tax system has long encouraged charitable
giving. Gifts to qualified charities may be deducted from
income otherwise subject to tax.
The amount one can deduct for income tax purposes in a
given year may be limited. Contributions of cash are
generally deductible in amounts up to 50% of a donor’s
“contribution base.” For most individuals, the
contribution base is the same as adjusted gross income
(AGI).

For gifts of securities and certain other properties that
have increased in value, the limit is normally 30% of
AGI. Any gifts of cash or other property in excess of these
limits may be carried over for use as a deduction in up to
five additional years.

A window of opportunity
Because many individuals may wish to make additional
gifts this year, they could encounter charitable deduction
limitations. Congress has temporarily suspended limits on
deductions for gifts of cash to qualified charities made
during the period beginning on August 28, 2005 and
ending on December 31, 2005. Thus, donors may deduct
qualified charitable gifts in amount up to 100% of their
AGI, if so desired.
Other limits that can reduce the value of itemized
deductions by 3% for some higher income taxpayers have
also been suspended for qualified contributions made
before the end of this year.
As always, consult your tax advisor but be aware of these
changes that might help you make an additional gift to
the University of Tennessee Medical Center or use this
window to make pledge payments that might otherwise
be due in the next few years.
Thanks to the Sharpe Group for assistance with this article.

Thanks to the generosity and thoughtful estate
planning of Dr. Lee A. Absher and his wife Reba
Q. Absher, $900,000 of a total of $1.3 million
bequest in their will was designated to help
support the Pastoral Care
Program. The Pastoral
Care Residency initiative
was greatly enhanced by this generous bequest.
UT Medical Center patients, their families, and
staff have the support of specially trained
chaplains available to help them through stress
caused by trauma and illness.

Thank You
Members of chaplain program in front
of the Absher Chapel.
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Gift Funds

Cancer Institute
Gift and Education Funds
Larry and Dorothy Stephens Cancer Care
Gift Fund
Supports cancer patients with medicine and
transportation

Cancer Institute Education and Research Gift
Fund, Paul T. and Dorothy B. Gillenwater
Cancer Gift Fund and Buford N. Irwin
Cancer Research Gift Fund
All support general cancer research and education

Breast Cancer Education/Outreach
Gift Fund

Anne A. Wallen Lung Cancer Gift Fund

Breast cancer research and education

Lung cancer research

The Reverend Vertrue Sharp Gift Fund

Prostate Cancer Research Gift Fund

Supporting scientific or medical research in cancer and
other prevalent diseases with supporting innovative
cancer education

Prostate cancer research, provides research grants for
promising clinical and basic research initiatives

Oscar Roe Bragg Cancer Gift Fund
Tinque Blakely Cancer Gift Fund
Cancer research and appreciation for cancer education

Supports cancer with an emphasis on lung and
esophageal cancer
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If you are a physician or allied healthcare professional, researcher, or faculty
member seeking continuing education, you may be interested in this sampling of
upcoming activities offered through the UT Graduate School of Medicine Office of
Continuing Medical and Dental Education.

CME Course Calendar
Winter 2006

2nd Annual
Hematology
Review

January 21, 2006
UT Conference Center
Knoxville, TN

This annual review serves as a follow-up and briefing to the
American Society of Hematology (ASH) international conference held
each year in December. Prominent physicians from across the country
will discuss new findings and updates to information presented at the
ASH meeting.

Health Literacy
Conference: Soul

February 8-11, 2006
Jackson Hole, WY

This conference will allow physicians to learn how to better assess
language needs, conduct motivational interviews with patients, break
communication and motivation barriers, and maintain the focus of a
medical provider. Attendees will participate in plenary sessions,
discussions, and the AMA's Train-the-Trainer workshops on health
literacy.

Spring/Summer 2006

The “D” Team

March 11, 2006
University Club
Knoxville, TN

This conference is focused on the latest techniques and medicines in
the treatment of diabetes. It is a conference designed for the whole
office as a team approach for battling this disease. From the front desk
staff to the physician, everyone is included in this learning experience.

April 4–9, 2006
Knoxville Marriott
Knoxville, TN

Lectures and workshops are designed to provide gastroenterologists,
nurses, and practice managers with information on planning and
operations, managing electronic medical records, and proven systems to
improve practice efficiencies in endoscopic ambulatory surgery centers.

Speak: Plain Talk about
Health Literacy in the
Physician-Patient
Partnership

2nd Annual
Diabetes Update

Gastroenterology
Practice &
Endoscopic
ASCs – Creating
Success 2006

29th Annual Family April 27-–29, 2006
Park Vista Resort
Medicine Update
Gatlinburg, TN

The 2006
Patterson Lecture:
Long-Term Health
Effects of Childhood

The format of this year’s update will follow the human life cycle. The
conference will cover the time periods of childhood, adolescence, adult,
and senior adult. Each time period will feature experts in the
appropriate specialties. The final day talks will be on the inevitability
of death and taxes featuring a tax attorney and the nationally known
forensic anthropologist Dr. Bill Bass.

May 19, 2006
UT Medical Center
Wood Auditorium
Knoxville, TN

Understanding that while the immediate and short-term effects of
childhood sexual abuse are generally known, physicians seeing adult
patients need information regarding the long-term effects of such a
history.

May 24–26, 2006
Grove Park Inn
Asheville, NC

This perinatal conference will focus on the specialties of obstetrics,
neonatology and pediatrics. Invited participants will include
physicians, physician assistants, nurse practitioners and others. The
faculty will be composed of the top specialists in the region.

Sexual Abuse

Life...Inside & Out
First Annual Perinatal
and Neonatal Care
Symposium

To register or for more information call 865-544-9190
or visit our website www.tennessee.edu/cme
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National Research Corporation

Consumer Choice Award
10 Years in a Row

www.utmedicalcenter.org

The University of Tennessee Cancer Institute focuses
on two things: cancer and the patient. The institute
provides advanced treatments, fast answers, expert
health professionals and the best personalized care,
so patients never feel like they are going through
cancer alone. A team of specialists meet throughout
the week to discuss a definitive diagnosis and
treatment for the best care plan for the patient so he
does not have to make multiple physician
appointments. This individualized and coordinated
cancer care makes the Cancer Institute a leader in
the region.
For more information about the Cancer Institute,
please call toll-free 1-877-UT-CARES or visit our
website at www.utmedicalcenter.org
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